CT125B CAR T cells (donor-derived CD5 CAR T)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CT125B CAR T cells (donor-derived CD5 CAR T), covering 2024-11-14 to 2024-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphoma [Phase 1]